Search

everythinglearnresearchcommunity

for

Search:↓

Puberty often causes skin issues like acne and excessive sweating, and treatments require patience as results may vary.

COVID-19 may harm male fertility and damage the reproductive system.

Korean patients with PCOS often have skin problems like acne and excess hair, with different symptoms based on their specific PCOS type.

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Polycystic ovary syndrome is a common hormonal disorder in women, linked to increased risk of metabolic and heart diseases, and needs more research for better understanding and treatment.

Menopausal acne is treated with medications and lifestyle changes, but careful choice is needed due to side effects.

Irregular menstrual cycles in teenagers are linked to a higher risk of polycystic ovary syndrome and metabolic syndrome.

Thyroid hormones and androgens affect gene expression in frog reproductive organs differently between males and females.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

Most hirsutism patients had idiopathic hirsutism or PCOS, with hormonal imbalances and signs like acne and irregular periods.

Some skin diseases and their treatments can negatively affect male fertility.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

We need better ways to test and understand SARMs to make safer and more effective treatments.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Finasteride affects frog testes by increasing testosterone, decreasing 5α-DHT, and impacting genes related to reproduction and other functions.

The document concludes that parathyroid diseases have a range of clinical features and outcomes, with some conditions being treatable and others having a high risk of mortality.

The new oral testosterone pill normalized testosterone levels and lowered SHBG in men with low testosterone.

Metformin improved menstrual cycle regularity and signs of hyperandrogenism in adolescent girls with type 1 diabetes but did not improve blood sugar control.

Serenoa repens (saw palmetto) may cause side effects like hot flashes in children and needs more research for safety in pediatric use.

New oral testosterone formulations show potential for safer, effective hormone replacement in men with low testosterone.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

The document concludes that diagnosing PCOS requires a thorough approach, considering various symptoms and risks, and calls for improved methods to identify PCOS types and prevent diabetes.

The review concludes that more research is needed to better improve the health outcomes for people with Polycystic Ovarian Syndrome.

A 63-year-old woman's male-like symptoms were caused by a rare testosterone-producing ovarian tumor, treated by removing her ovaries and fallopian tubes.

Two types of 5α-reductase are in dog skin, which might make dutasteride better than finasteride for treating dog hair loss.